Cardio-Oncology Spotlight: Isabella Mahe, A Post-Hoc Analysis of a Randomised, Non-Inferiority Trial (API-CAT)

Dr. Isabella Mahe is the first author of the API-CAT trial and in this episode she reviews predictors associated with clinically relevant bleeding. Join us for for an in-depth discussion on predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism: a post-hoc analysis of a randomised, non-inferiority trial (API-CAT).